Finance

Lists
300636:SHE
Jiangxi Synergy Pharmaceutical Co Ltd
CNÂ¥7.04
+0.43%
(+0.030) 1D
Sep 24, 3:04:28 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300636...
Open
CNÂ¥6.98
High
CNÂ¥7.09
Low
CNÂ¥6.98
Mkt. cap
2.96B
Avg. vol.
5.57M
Volume
3.89M
Dividend
0.57%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 3, 2026
P/E ratio
75.49
52-wk high
CNÂ¥8.93
52-wk low
CNÂ¥6.11
EPS
CNÂ¥0.09
Shares outstanding
419.95M
No. of employees
2K
Open
CNÂ¥6.98
High
CNÂ¥7.09
Low
CNÂ¥6.98
Mkt. cap
2.96B
Avg. vol.
5.57M
Volume
3.89M
Dividend
0.57%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
Jun 3, 2026
P/E ratio
75.49
52-wk high
CNÂ¥8.93
52-wk low
CNÂ¥6.11
EPS
CNÂ¥0.09
Shares outstanding
419.95M
No. of employees
2K
About Jiangxi Synergy Pharmaceutical Co Ltd
CEO-
Employees1.62K
FoundedApr 20, 2004
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
208.82M
192.42M
184.39M
198.77M
Cost of goods sold
120.66M
199.99M
131.75M
143.65M
Cost of revenue
120.66M
199.99M
131.75M
143.65M
Research and development expenses
14.39M
23.96M
15.51M
20.45M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.28M
19.11M
16.05M
19.58M
Operating expense
33.51M
44.05M
29.36M
40.75M
Total operating expenses
154.17M
244.04M
161.11M
184.41M
Operating income
54.65M
-51.62M
23.29M
14.36M
Other non operating income
3.20M
-3.77M
-863.12K
-5.23M
EBT including unusual items
27.84M
-16.84M
19.62M
961.86K
EBT excluding unusual items
56.95M
-51.51M
20.10M
11.46M
Income tax expense
2.66M
-6.27M
836.49K
-4.83M
Effective tax rate
9.55%
37.22%
4.26%
-502.11%
Other operating expenses
301.57K
1.24M
-2.65M
1.18M
Net income
25.18M
-10.57M
18.78M
5.79M
Net profit margin
12.06%
-5.49%
10.18%
2.91%
Earnings per share
-
-
-
-
Interest and investment income
6.16M
5.57M
-
2.33M
Interest expense
-2.98M
-2.95M
-2.33M
-
Net interest expenses
3.17M
2.61M
-2.33M
2.33M
Depreciation and amortization charges
-
-
-
-
EBITDA
83.08M
-19.08M
55.82M
50.08M
Gain or loss from assets sale
-194.30K
767.63K
-
63.55K
AI content may include mistakes. Learn more
Google apps